快速发展的免疫治疗在慢性活跃的爱斯坦-巴尔病毒疾病中的作用
Sijia Yan1, Xi Ming1, Xiaojian Zhu1
1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Frontiers in immunology
|December 18, 2024
概括
长期活跃的爱斯坦-巴尔病毒疾病缺乏标准治疗方法,但可以通过控制炎症,瘤增殖和免疫复原来控制. 造血干细胞移植提供了治愈方法,而免疫疗法则显示出有前途.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 慢性活跃的爱斯坦-巴尔病毒 (CAEBV) 是一种与爱斯坦-巴尔病毒相关的T/NK细胞淋巴增殖性疾病.
- 目前的治疗缺乏标准化,专注于炎症控制,抗瘤扩散和免疫复合.
研究的目的:
- 审查慢性活跃爱斯坦-巴尔病毒疾病的当前治疗策略.
- 突出血造干细胞移植和新兴免疫疗法的作用.
主要方法:
- 对CAEBV.的现有治疗方法的文献综述.
- 免疫治疗的疗效和安全性的分析,包括PD-1抑制剂和埃普斯坦-巴尔病毒特异性T细胞.
主要成果:
- 造血干细胞移植是CAEBV的唯一治愈选择.
- 免疫疗法,如PD-1抑制剂和爱斯坦-巴尔病毒特异性T细胞,在控制CAEBV.中显示出安全性和有效性.
结论:
- 有效管理CAEBV需要一个多方面的方法.
- 免疫疗法代表了CAEBV治疗的有希望的途径,提供了独特的优势.
相关概念视频
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
Cancer Vaccines
338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338
Immune Response Against Viral Pathogens
745
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
745
Retrovirus Life Cycles
45.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.6K


